Krsnaa Diagnostics Ltd (KRSNAA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003520,
    "name": "Krsnaa Diagnost.",
    "stock_name": "Krsnaa Diagnost.",
    "full_name": "Krsnaa Diagnostics Ltd",
    "name_url": "stocks-analysis/krsnaa-diagnost",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "709.10",
    "chg": 11.3,
    "chgp": "1.62%",
    "dir": 1,
    "prev_price": "697.80",
    "mcapval": "2,352.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543328,
    "symbol": "KRSNAA",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE08LI01020",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "99.53 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/krsnaa-diagnost-1003520-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Krsnaa Diagnost. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-krsnaa-diagnost-technically-bullish-or-bearish-3745665",
        "imagepath": "",
        "date": "2025-12-04 08:45:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Technical Indicators</strong></p>\n<p>The latest technical data as of 03 Dec 2025 reveals a nuanced picture for Krsnaa Diagnost. The overall trend has transitioned from sideways to mildly bearish, indicating a subtle but notable shift in market momentum. Key momentum indicators such as the Moving Average Convergence Divergence (MACD) on both weekly and monthly charts are mildly bearish, signalling that downward pressure may be building.</p>\n<p>Similarly, the Bollinger Bands on weekly and monthly timeframes are bearish, suggesting that the stock price is trading near the lower band, which often reflects increased volatility and potential downside risk. The Know Sure Thing (KST) indicator, which helps identify major price cycles, also aligns with a mildly bearish outlook on weekly a..."
      },
      {
        "title": "Krsnaa Diagnostics Technical Momentum Shifts Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krsnaa-diagnostics-faces-mildly-bearish-technical-shift-amid-market-underperformance-3745540",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KrsnaaDiagnosti_technicaldot_3745540.png",
        "date": "2025-12-04 08:12:25",
        "description": "Krsnaa Diagnostics has experienced a notable shift in its technical momentum, reflecting evolving market dynamics within the healthcare services sector. Recent assessment changes reveal a transition from a sideways trend to a mildly bearish stance, with key technical indicators signalling nuanced movements in price momentum and investor sentiment."
      },
      {
        "title": "Krsnaa Diagnostics: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krsnaa-diagnostics-downgraded-to-sell-amid-technical-and-financial-concerns-3743163",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KrsnaaDiagnosti_mojoScore_3743163.png",
        "date": "2025-12-03 08:27:45",
        "description": "Krsnaa Diagnostics has experienced a revision in its market assessment following a detailed evaluation of its quality, valuation, financial trends, and technical indicators. The healthcare services company’s recent performance and market behaviour have prompted a nuanced reassessment, reflecting a complex interplay of factors that investors should carefully consider."
      },
      {
        "title": "Krsnaa Diagnostics Faces Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krsnaa-diagnostics-faces-technical-momentum-shift-amid-bearish-signals-3743042",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KrsnaaDiagnosti_technicaldot_3743042.png",
        "date": "2025-12-03 08:08:58",
        "description": "Krsnaa Diagnostics has experienced a notable shift in its technical landscape, with recent evaluation adjustments reflecting a transition from a mildly bullish trend to a sideways momentum. The stock’s price action, combined with key technical indicators such as MACD, RSI, and moving averages, presents a complex picture for investors navigating the healthcare services sector."
      },
      {
        "title": "How has been the historical performance of Krsnaa Diagnost.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-krsnaa-diagnost-3742282",
        "imagepath": "",
        "date": "2025-12-02 23:06:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Over the four-year period, Krsnaa Diagnost. has seen its net sales increase steadily from ₹455.45 crores in March 2022 to ₹717.16 crores in March 2025. This represents a compound growth trend reflecting the company’s expanding market presence and operational scale. Total operating income mirrored this growth, with no other operating income reported, indicating that core business activities have been the primary revenue drivers.</p>\n<p>Operating profit before depreciation and interest (PBDIT excluding other income) rose from ₹131.48 crores in March 2022 to ₹190.12 crores in March 2025, signalling improved operational efficiency. Including other income, operating profit (PBDIT) increased from ₹146.39 crores to ₹215.66 crores over the same period. Howev..."
      },
      {
        "title": "Is Krsnaa Diagnost. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-krsnaa-diagnost-overvalued-or-undervalued-3709961",
        "imagepath": "",
        "date": "2025-11-18 08:25:37",
        "description": "As of 17 November 2025, Krsnaa Diagnostics has moved from a very attractive to an attractive valuation grade. The company is currently considered fairly valued. Key ratios include a PE ratio of 31.76, an EV to EBITDA of 13.62, and a PEG ratio of 1.47. \n\nIn comparison to peers, Krsnaa Diagnostics has a lower PE ratio than Apollo Hospitals, which stands at 64.41, indicating that Krsnaa may be more reasonably priced despite its attractive valuation. Other peers like Max Healthcare and Fortis Healthcare are significantly more expensive, with PE ratios of 77.22 and 70.78, respectively. Although Krsnaa Diagnostics has underperformed the Sensex year-to-date, it has shown strong returns over the past three years, outperforming the index with a return of 79.08%...."
      },
      {
        "title": "Krsnaa Diagnostics Adjusts Valuation Amid Strong Performance in Healthcare Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krsnaa-diagnostics-valuation-grade-downgraded-from-very-attractive-to-attractive-3710090",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KrsnaaDiagnosti_valuationdot_3710090.png",
        "date": "2025-11-18 08:03:42",
        "description": "Krsnaa Diagnostics, a small-cap healthcare services company, has recently adjusted its valuation, with its stock price rising to 828.05. The company has outperformed the Sensex over the past week, showcasing strong financial metrics, including a PE ratio of 31.76 and a favorable position compared to industry competitors."
      },
      {
        "title": "Krsnaa Diagnostics Reports Flat Financial Performance Amid Mixed Operational Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krsnaa-diagnostics-stock-rating-adjusted-to-hold-amid-flat-financial-results-3696710",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KrsnaaDiagnosti_mojoScore_3696710.png",
        "date": "2025-11-13 08:26:04",
        "description": "Krsnaa Diagnostics has recently adjusted its evaluation based on its financial performance for the quarter ending September 2025, reporting flat results. The company achieved record operating cash flow and net sales, while also facing challenges in certain financial metrics. Institutional investor participation has increased, reflecting a favorable valuation profile."
      },
      {
        "title": "How has been the historical performance of Krsnaa Diagnost.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-krsnaa-diagnost-3695692",
        "imagepath": "",
        "date": "2025-11-13 00:35:46",
        "description": "Answer:\nThe historical performance of Krsnaa Diagnost shows a consistent growth trajectory in net sales and profits over the past four years.\n\nBreakdown:\nKrsnaa Diagnost's net sales have increased from 455.45 Cr in March 2022 to 717.16 Cr in March 2025, indicating a strong upward trend. Total operating income followed a similar pattern, rising from 455.45 Cr in March 2022 to 717.16 Cr in March 2025. The company's total expenditure, excluding depreciation, also grew from 323.97 Cr in March 2022 to 527.04 Cr in March 2025, reflecting increased operational costs. Operating profit (PBDIT) rose from 146.39 Cr in March 2022 to 215.66 Cr in March 2025, while profit before tax improved from 86.51 Cr to 102.69 Cr in the same period. Profit after tax saw fluctuations, peaking at 77.61 Cr in March 2025, compared to 68.39 Cr in March 2022. The earnings per share (EPS) increased from 21.78 in March 2022 to 24.03 in Marc..."
      }
    ],
    "total": 256,
    "sid": "1003520",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/krsnaa-diagnostics-1003520"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "30-Jan-2026",
      "details": "Update on Investor Call.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "30-Jan-2026",
      "details": "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 -Analyst / Institutional Investor Meeting scheduled to be held on February 10 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.",
      "datetime": "28-Jan-2026",
      "details": "Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 inter alia to consider and approve Pursuant to the provisions of Regulation 29(1) & (2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday February 05 2026 inter-alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Krsnaa Diagnostics Ltd has declared <strong>55%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Krsnaa Diagnost. technically bullish or bearish?

2025-12-04 08:45:41

Overview of Technical Indicators The latest technical data as of 03 Dec 2025 reveals a nuanced picture for Krsnaa Diagnost. The overall trend has transitioned from sideways to mildly bearish, indicating a subtle but notable shift in market momentum. Key momentum indicators such as the Moving Average Convergence Divergence (MACD) on both weekly and monthly charts are mildly bearish, signalling that downward pressure may be building. Similarly, the Bollinger Bands on weekly and monthly timeframes are bearish, suggesting that the stock price is trading near the lower band, which often reflects increased volatility and potential downside risk. The Know Sure Thing (KST) indicator, which helps identify major price cycles, also aligns with a mildly bearish outlook on weekly a...

Krsnaa Diagnostics Technical Momentum Shifts Amid Market Volatility

2025-12-04 08:12:25

Krsnaa Diagnostics has experienced a notable shift in its technical momentum, reflecting evolving market dynamics within the healthcare services sector. Recent assessment changes reveal a transition from a sideways trend to a mildly bearish stance, with key technical indicators signalling nuanced movements in price momentum and investor sentiment.

Krsnaa Diagnostics: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals

2025-12-03 08:27:45

Krsnaa Diagnostics has experienced a revision in its market assessment following a detailed evaluation of its quality, valuation, financial trends, and technical indicators. The healthcare services company’s recent performance and market behaviour have prompted a nuanced reassessment, reflecting a complex interplay of factors that investors should carefully consider.

Krsnaa Diagnostics Faces Mixed Technical Signals Amid Price Momentum Shift

2025-12-03 08:08:58

Krsnaa Diagnostics has experienced a notable shift in its technical landscape, with recent evaluation adjustments reflecting a transition from a mildly bullish trend to a sideways momentum. The stock’s price action, combined with key technical indicators such as MACD, RSI, and moving averages, presents a complex picture for investors navigating the healthcare services sector.

How has been the historical performance of Krsnaa Diagnost.?

2025-12-02 23:06:26

Revenue and Profit Growth Over the four-year period, Krsnaa Diagnost. has seen its net sales increase steadily from ₹455.45 crores in March 2022 to ₹717.16 crores in March 2025. This represents a compound growth trend reflecting the company’s expanding market presence and operational scale. Total operating income mirrored this growth, with no other operating income reported, indicating that core business activities have been the primary revenue drivers. Operating profit before depreciation and interest (PBDIT excluding other income) rose from ₹131.48 crores in March 2022 to ₹190.12 crores in March 2025, signalling improved operational efficiency. Including other income, operating profit (PBDIT) increased from ₹146.39 crores to ₹215.66 crores over the same period. Howev...

Is Krsnaa Diagnost. overvalued or undervalued?

2025-11-18 08:25:37

As of 17 November 2025, Krsnaa Diagnostics has moved from a very attractive to an attractive valuation grade. The company is currently considered fairly valued. Key ratios include a PE ratio of 31.76, an EV to EBITDA of 13.62, and a PEG ratio of 1.47. In comparison to peers, Krsnaa Diagnostics has a lower PE ratio than Apollo Hospitals, which stands at 64.41, indicating that Krsnaa may be more reasonably priced despite its attractive valuation. Other peers like Max Healthcare and Fortis Healthcare are significantly more expensive, with PE ratios of 77.22 and 70.78, respectively. Although Krsnaa Diagnostics has underperformed the Sensex year-to-date, it has shown strong returns over the past three years, outperforming the index with a return of 79.08%....

Krsnaa Diagnostics Adjusts Valuation Amid Strong Performance in Healthcare Sector

2025-11-18 08:03:42

Krsnaa Diagnostics, a small-cap healthcare services company, has recently adjusted its valuation, with its stock price rising to 828.05. The company has outperformed the Sensex over the past week, showcasing strong financial metrics, including a PE ratio of 31.76 and a favorable position compared to industry competitors.

Krsnaa Diagnostics Reports Flat Financial Performance Amid Mixed Operational Metrics

2025-11-13 08:26:04

Krsnaa Diagnostics has recently adjusted its evaluation based on its financial performance for the quarter ending September 2025, reporting flat results. The company achieved record operating cash flow and net sales, while also facing challenges in certain financial metrics. Institutional investor participation has increased, reflecting a favorable valuation profile.

How has been the historical performance of Krsnaa Diagnost.?

2025-11-13 00:35:46

Answer: The historical performance of Krsnaa Diagnost shows a consistent growth trajectory in net sales and profits over the past four years. Breakdown: Krsnaa Diagnost's net sales have increased from 455.45 Cr in March 2022 to 717.16 Cr in March 2025, indicating a strong upward trend. Total operating income followed a similar pattern, rising from 455.45 Cr in March 2022 to 717.16 Cr in March 2025. The company's total expenditure, excluding depreciation, also grew from 323.97 Cr in March 2022 to 527.04 Cr in March 2025, reflecting increased operational costs. Operating profit (PBDIT) rose from 146.39 Cr in March 2022 to 215.66 Cr in March 2025, while profit before tax improved from 86.51 Cr to 102.69 Cr in the same period. Profit after tax saw fluctuations, peaking at 77.61 Cr in March 2025, compared to 68.39 Cr in March 2022. The earnings per share (EPS) increased from 21.78 in March 2022 to 24.03 in Marc...

View All News